Business Description
Kukjeon Pharmaceutical Co Ltd
ISIN : KR7307750000
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.75 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.81 | |||||
Debt-to-EBITDA | 10.19 | |||||
Interest Coverage | 0.84 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.15 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.2 | |||||
3-Year Book Growth Rate | 36.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.96 | |||||
9-Day RSI | 40.38 | |||||
14-Day RSI | 41.7 | |||||
6-1 Month Momentum % | -6.41 | |||||
12-1 Month Momentum % | -13.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 0.93 | |||||
Cash Ratio | 0.56 | |||||
Days Inventory | 95.85 | |||||
Days Sales Outstanding | 83.18 | |||||
Days Payable | 48.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.18 | |||||
Dividend Payout Ratio | 0.16 | |||||
Forward Dividend Yield % | 0.18 | |||||
5-Year Yield-on-Cost % | 0.18 | |||||
3-Year Average Share Buyback Ratio | -5.7 | |||||
Shareholder Yield % | -5.51 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 19.24 | |||||
Operating Margin % | 4.18 | |||||
Net Margin % | 1.04 | |||||
FCF Margin % | -13.68 | |||||
ROE % | 1.42 | |||||
ROA % | 0.62 | |||||
ROIC % | -1.21 | |||||
ROC (Joel Greenblatt) % | 4.25 | |||||
ROCE % | 3.09 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 206.3 | |||||
PE Ratio without NRI | 88.86 | |||||
PS Ratio | 2.12 | |||||
PB Ratio | 2.82 | |||||
Price-to-Tangible-Book | 2.95 | |||||
Price-to-Operating-Cash-Flow | 34.45 | |||||
EV-to-EBIT | 75.87 | |||||
EV-to-EBITDA | 38.2 | |||||
EV-to-Revenue | 2.26 | |||||
EV-to-FCF | -16.54 | |||||
Price-to-Graham-Number | 3.41 | |||||
Earnings Yield (Greenblatt) % | 1.32 | |||||
FCF Yield % | -6.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kukjeon Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 129,429.106 | ||
EPS (TTM) (â‚©) | 27 | ||
Beta | -0.13 | ||
Volatility % | 29.87 | ||
14-Day RSI | 41.7 | ||
14-Day ATR (â‚©) | 140.10816 | ||
20-Day SMA (â‚©) | 5605 | ||
12-1 Month Momentum % | -13.69 | ||
52-Week Range (â‚©) | 5420 - 8140 | ||
Shares Outstanding (Mil) | 49.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kukjeon Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kukjeon Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kukjeon Pharmaceutical Co Ltd Frequently Asked Questions
What is Kukjeon Pharmaceutical Co Ltd(XKRX:307750)'s stock price today?
When is next earnings date of Kukjeon Pharmaceutical Co Ltd(XKRX:307750)?
Does Kukjeon Pharmaceutical Co Ltd(XKRX:307750) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |